Skyline Global Partners

All investment decisions appear to be made by the three managing partners: Ross Christianson, Chris Freeburg, and Sachin Gupta. The firm has not disclosed any additional investment committee members, principals, or advisory board. Their direct contact information is listed publicly on the firm's website, indicating a flat and accessible decision-making structure.

The firm operates as a limited liability company with a single office in Chicago. It does not publicly identify any fund vehicles, suggesting it may invest through committed capital or structured equity. The partnership structure is lean, with no publicly identified operating businesses or philanthropic arms.

Skyline Global Partners' stated strategy covers buyouts, growth equity, management buyouts, recapitalizations, and general venture investments. Its portfolio companies, such as Captek Softgel and iMDsoft, suggest an emphasis on later-stage, profitable businesses rather than early-stage venture startups.

The firm's disclosed portfolio concentrates on three specific areas: pharmaceuticals and life sciences through Captek Softgel, enterprise software through iMDsoft, and healthcare services through Patient Care America. There is no indication the firm has invested outside these sectors.

No public record of fund families or vintage years exists. Skyline Global Partners appears to manage a concentrated portfolio of three platform companies without the traditional private equity fund structure, which contrasts with peers that raise successive blind-pool funds.